HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Control of in vitro immune responses by regulatory oligodeoxynucleotides through inhibition of pIII promoter directed expression of MHC class II transactivator in human primary monocytes.

Abstract
Ag presentation is a key step in the initiation of adaptive immune responses that depends on the expression of MHC Ags and costimulatory molecules. Immune-enhancing CpG and non-CPG oligodeoxynucleotides (ODNs) stimulate Ag presentation by stimulating the expression of these molecules and by promoting dendritic cell maturation. In this report, we identify immunoregulatory orthophosphorothioate non-CpG molecules, referred to as regulatory ODNs (rODNs), by their ability to inhibit allogeneic monocyte-stimulated T cell responses and down-regulate HLA-DR in human primary monocytes. The rODNs promoted the survival of macrophages and were able to activate IL-8 secretion through a chloroquine-resistant pathway. Messenger RNAs for HLA-DR alpha and beta and the MHC CIITA were reduced by rODNs but not by stimulatory CpG ODN2006 and non-CpG ODN2006a. CIITA transcription in monocytes was controlled primarily by promoter III and not by promoter I or IV. rODNs blocked promoter III-directed transcription of CIITA in these cells. Under conditions that induced dendritic cell differentiation, rODNs also reduced HLA-DR expression. The activity of rODNs is phosphorothioate chemistry and G stretch dependent but TLR9 independent. G tetrads were detected by circular dichroism in active rODNs and associated with high m.w. multimers on nondenaturing gels. Heat treatment of rODNs disrupted G tetrads, the high m.w. aggregates, and the HLA-DR inhibitory activity of the ODNs. The inhibition of immune responses by regulatory oligodeoxynucleotides may be useful for the treatment of immune-mediated disorders including autoimmune diseases and graft rejection.
AuthorsJinhai Wang, Gregory Roderiquez, Taneishia Jones, Peter McPhie, Michael A Norcross
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 179 Issue 1 Pg. 45-52 (Jul 01 2007) ISSN: 0022-1767 [Print] United States
PMID17579020 (Publication Type: Journal Article)
Chemical References
  • Adjuvants, Immunologic
  • CPG-oligonucleotide
  • Growth Inhibitors
  • HLA-DR Antigens
  • HLA-DR alpha-Chains
  • Isoantigens
  • MHC class II transactivator protein
  • Nuclear Proteins
  • Oligodeoxyribonucleotides
  • Trans-Activators
Topics
  • Adjuvants, Immunologic (pharmacology)
  • Cell Proliferation
  • Cells, Cultured
  • Down-Regulation (immunology)
  • Growth Inhibitors (physiology)
  • HLA-DR Antigens (biosynthesis, metabolism)
  • HLA-DR alpha-Chains
  • Humans
  • Isoantigens (pharmacology)
  • Monocytes (immunology, metabolism)
  • Nuclear Proteins (antagonists & inhibitors, biosynthesis, genetics)
  • Oligodeoxyribonucleotides (pharmacology)
  • Promoter Regions, Genetic (genetics, immunology)
  • T-Lymphocytes (cytology, immunology)
  • Trans-Activators (antagonists & inhibitors, biosynthesis, genetics)
  • Transcription, Genetic (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: